Internal medicine

Nanotechnology

Immunotherapy

Cancer immunotherapy

Cancer

Nanomedicine

Nanoparticle

Materials science

Immunology

Drug delivery

Immune checkpoint

Cancer therapy

Cancer research

Radiation therapy

Medicine

Immune system

Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology

Cancer immunotherapy aims to leverage the immune system to suppress the growth of tumors and to inhibit metastasis. The recent promising clinical outcomes associated with cancer immunotherapy have prompted research and development efforts towards enhancing the efficacy of immune checkpoint blockade, cancer vaccines, cytokine therapy, and adoptive T cell therapy. Advancements in biomaterials, nanomedicine, and micro‐/nano‐technology have facilitated the development of enhanced local delivery systems for cancer immunotherapy, which can enhance treatment efficacy while minimizing toxicity. Furthermore, locally administered cancer therapies that combine immunotherapy with chemotherapy, radiotherapy, or phototherapy have the potential to achieve synergistic antitumor effects. Herein, the latest studies on local delivery systems for cancer immunotherapy are surveyed, with an emphasis on the therapeutic benefits associated with the design of biomaterials and nanomedicines. This article is categorized under: Nanotechnology Approaches to Biology &gt; Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery &gt; Nanomedicine for Oncologic Disease

Advances in engineering local drug delivery systems for cancer immunotherapy